These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8164850)

  • 21. Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis.
    Moon SY; Lee SS; Hong YH
    J Clin Neurosci; 2011 Sep; 18(9):1274-5. PubMed ID: 21741841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT; Bienfang DC
    J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor.
    Bever CT; Chang HW; Penn AS; Jaffe IA; Bock E
    Neurology; 1982 Oct; 32(10):1077-82. PubMed ID: 6889694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.
    Chan JW; Orrison WW
    Br J Ophthalmol; 2007 Jun; 91(6):842-3. PubMed ID: 17510484
    [No Abstract]   [Full Text] [Related]  

  • 25. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
    Farrugia ME; Kennett RP; Newsom-Davis J; Hilton-Jones D; Vincent A
    Muscle Nerve; 2006 Apr; 33(4):568-70. PubMed ID: 16382443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electromyography of eye muscles in myasthenia gravis].
    Tietze K; Glatzel W
    Psychiatr Neurol Med Psychol (Leipz); 1980 Feb; 32(2):111-5. PubMed ID: 7394081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation.
    Wilson S; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):377-82. PubMed ID: 6101171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates.
    Pestronk A; Drachman DB; Self SG
    Muscle Nerve; 1985; 8(3):245-51. PubMed ID: 4058469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular presentation of myasthenia gravis: A natural history cohort.
    Kamarajah SK; Sadalage G; Palmer J; Carley H; Maddison P; Sivaguru A
    Muscle Nerve; 2018 Apr; 57(4):622-627. PubMed ID: 28881457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis.
    Beeson D; Jacobson L; Newsom-Davis J; Vincent A
    Neurology; 1996 Dec; 47(6):1552-5. PubMed ID: 8960744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of myasthenia gravis antibodies to different acetylcholine receptor preparations.
    Zielinski A; Brenner T; Abramsky O
    Isr J Med Sci; 1982 Apr; 18(4):483-6. PubMed ID: 7085248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular myasthenia. Differences between the ocular and the generalized form of myasthenia.
    Schmidt D
    Bull Soc Belge Ophtalmol; 1989; 237():353-80. PubMed ID: 2486115
    [No Abstract]   [Full Text] [Related]  

  • 35. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The neuromuscular junction in myasthenia. Human and experimental morphological data (author's transl)].
    Fardeau M
    Ann Chir; 1980 Mar; 34(3):140-6. PubMed ID: 6989315
    [No Abstract]   [Full Text] [Related]  

  • 37. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type.
    Nakamura H; Taniguchi Y; Suzuki Y; Tanaka Y; Ishiguro K; Fukuda M; Hara H; Mori T
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):371-5. PubMed ID: 8751505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new test for ocular myasthenia gravis? OMG!
    Prasad S; Halmagyi GM
    Neurology; 2016 Feb; 86(7):590-1. PubMed ID: 26791150
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.